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A positive statistical correlation between intercellular 
antibody titer and disease severity was found for a group 
of 6 patients with active pemphigus vulgaris, irrespec-
tive of whether indirect IF testing was performed on 5 
different epithelial substrates which included guinea pig 
esophagus, human foreskin, rabbit esophagus, monkey 
esophagus and monkey lip. In a group of 4 patients with 
pemphigus foliaceus a positive correlation between dis-
ease severity and titer was found only when rabbit 
esophagus was used for indirect fluorescence testing. In 
both groups of patients there were individual patients in 
whom the antibody titer was positive at a time when no 
disease was present and conversely, there were some 
patients in whom tbe antibody titer was negative at a 
time when extensive disease was present. Because of 
this inconsistency, the use of antibody titers to monitor 
disease activity and therapy in individual patients may 
not be justifiable. 
In pemphigus intercellular anti-epithelial antibodies can be 
detected in the serum of some patients by the indirect immu-
nofluorescence (IF) technique [1,2]. While intercellular anti-
bodies are not species specific and react with human, monkey, 
guinea pig and rabbit epithelial substrates [3J, 'they are organ 
specific and react only with squamous epithelium [1]. Several 
authors [4-6] have concluded that the level of these circulating 
anti-epithelial antibodies in patients with pemphigus correlated 
with disease activity. In a recent study' several patients with 
active and inactive pemphigus vulgaris or foliaceus were iden-
tified in whom changes in antibody titers did not reflect changes 
in disease activity. In this study' guinea pig 'esophagus was 
used as antigen for indirect IF testing as opposed to monkey 
epithelium [4-6]. In order to determine whether any specific 
epithelial source was superior for indirect IF -testing of sera 
from pemphigus pat ients, sera was repeatedly collected from 10 
patients with active pemphigus and indirect IF testing was 
performed on these sera simultaneously against 5 different 
epithelial substrates. 
MATERIALS AND METHODS 
Patients 
Six patients with active pemphigus vulgaris and 4 patients with 
active pemphigus foliaceus were studied. The clinical diagnosis was 
confirmed in all patients by histologic examination. All patients had 
intercellular epithelial deposition of IgG by direct IF testing. Serum 
samples were collected from each patient on the dates indicated in the 
Table. Six patients received massive prednisone therapy followed by 
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maintenance therapy and the other 4 patients received maintenance 
therapy only as previously described [7]. 
Clinical disease severity was grated as follows: 0 = no lesions; + = 
slight involvement; ++ = moderate involvement; +++ = extensive 
involvement; and ++++ = very extensive involvement. ' 
Immunoflu orescence Testing 
Indirect IF testing was performed by a modification of the method 
described by Beutner and Jordon [1]. Commercially available (Hyland) 
goat antihuman IgG with a fluorescein-to-protein ratio of 3.0 ± 0.5:1 
was used. Serum samples were collected from clotted blood after 
overnight storage at 4°C. ALI sera and conjugate were absorbed with 
'I:, volume of a AB+ human erythrocyte powder which was prepared by 
distilled water lysis followed by acetone dehydration. All sera and 
conjugate were stored at -80DC until processing. Indirect IF testing 
was performed 'on the following substrates; Hartley strain guinea pig 
esophagus, human infant foreskin, Swiss albino rabbit esophagus, Rhe-
sus monkey esophagus and Rhesus monkey 'lip. AI:! substrates were 
embedded in D.T.C. (Lab Tek Products Co.) and snap frozen in liquid 
nitrogen within one hour of biopsy or necropsy. The tissue substrates 
were stored at -BODC. 
SLa~is'/Jics 
Acnti~epit1belial intercellular IgG titers from each patient's sera were 
p'lotted ~ga~nst :the clinical disease severity of each respective patient 
at Ithe time of sallilpling. A Spearman rank correlation coefficient (r,) 
[8] and p value was separately obtained for patients with pemphigus 
v.u~garis and f0liaceus for -each epithelial substrate tested. 
RESULTS 
'The .antihody titers of repeatedly collected serum samples in 
6 patients with active pemphigus vulgaris and 4 patients with 
Il'lemphigus foliaceus are shown in the Table. There is a statis-
tically significant positive correlation between disease severity 
and titer in pemphigus vulgaris for each epithelial substrate 
used ; i ,e., 19uinea pig esophagus ,(:}:. = .63, P < .001), human 
foreskin :(Il's = .59, P < .001), rabbit .esophagus (r, = .52, P < .01), 
monkey 'esophagus (r8 = .79, P < :001), and monkey lip (r8 = .75, 
p < .001) . In pemphigus foliaceus a statistically significant 
positive correlation between disease severity and antibody titer 
was seen only with rabbit esophagus (r8 = .61, p < .01). It must 
be emphasized that wide variation in titer (greater than 2-tube 
dilutions) was noted in patients with either pemphigus vulgaris 
or foliaceus when the same serum sample was titered against 
the different epithelial substrates. No one substrate yielded 
consistently high or low titers. 
Three distinct indirect IF staining patterns were observed 
with sera obtained from patients with active pemphigus. Bright 
intercellular staining extending throughout the epithelium was 
the most common pattern seen in all substrates and was usually 
detectable in a titer of 1:40 or greater and in some instances at 
a titer of 1:20. Not infrequently, a second staining pattern of 
dull fluorescence localized to the intercellular space of the basal 
and lower spinous layers of the epithelium was seen. The titer 
of sera with this fluorescence pattern was never greater than 
1:20. Sera from one patient each with pemphigus vulgaris and 
pemphigus foliaceus showed granular epidermal nuclear stain-
ing. The development of these epithelial nuclear antibodies 
occurred in each patient following clinical clearing of their 
disease. 
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Changes in disease severity and intercellu.lar IgG titers in patients with active pemphigus 
Patient No. T ype of pemphi-
gus 
P vulg. 
2 P. vulg. 
3 P. vulg. 
4 P. vulg. 
5 P. vulg. 
6 P. vulg. 
7 P. fol. 
8 P . fol. 
9 P. fol. 
10 P. fol. 
Date 
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06-07-77 
08-09-77 
10-11-77 
12-13-77 
03-08-77 
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Star t high dosage pred-
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Start high dosage pred-
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nisone X 6 weeks 
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" = GPE (guinea pig esophagus), HFS (human foreskin) , RE (rabbit esophagus), ME (monkey esophagus), and ML (monkey lip) 
b = sera which show dull fluorescence in lower epithelial layers 
'.' = sera which show epithelial nuclear fluorescence only 
d = Stmt therapy on dates indicated following serum collection; maintenance t herapy included low dose prednisone plus either Imuran, 
Cytoxan, or Methotrexate [7]. 
COMMENTS 
The widely held belief that intercellular antibody titer cor-
relates with disease severity III patients with pemphigus is 
supported by the present study in part with some notable 
exceptions. In patients with active pemphigus vulgaris a positive 
correlation between titer and disease severity was found for 5 
different epithelial substrates utilized for indirect IF testing. 
While all 5 substrates yielded a positive statistical correlation, 
monkey tissue, including esophagus and lip, was slightly better 
than guinea pig esophagus, rabbit esophagus, or human foreskin 
by virtue of a higher rank correlation coefficient. The choice of 
a substrate other than monkey tissue should be viewed with 
some caution because an early study [3] indicated that some 
pemphigus sera did not react with substrates other than mon-
key. In the present study the converse was true in several 
patients (patients I, 4, 5, 8 and 10) in whom intercellular 
antibody titers of 1:40 or greater against non-monkey tissue 
were detected at a time when the antibody t iter against monkey 
tissue was O. If monkey tissue becomes difficult to obtain in the 
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future then guinea pig, rabbit or human tissue may be used 
without either of the latter three having clear superiority over 
the other. 
In pemphigus foliaceus a positive statistical correlation be-
tween disease severity and titer was obtained with rabbit esoph-
agus only. The reason for the lack of statistical correlation for 
the other substrates may relate to the small number of patients 
studied and/or the wide variations in titers in patients with 
pemphigus foliaceus. 
It is very important to emphasize that whichever substrate is 
used, there are some patients with either pemphigus vulgaris or 
pemphigus foliaceus in whom antibody titers may be low in the 
presence of extensive disease or in whom antibody titers may 
be high in the presence of minimal or no active disease. Thus 
as suggested in a recent study* in a large group of patients with 
pemphigus, the use of antibody titer to monitor disease activity 
and therapy in an individual patient may not be justifiable. 
Three distinct staining patterns were observed when sera 
from patients with active pemphigus were tested by indirect IF. 
The most common pattern which was observed on all substrates 
was bright intercellular fluorescence which was distributed 
throughout the malpigian layer of the epidermis. This pattern 
is regarded by some authors as characteristic of pemphigus 
[4,9,10]. Dull intercellular fluorescence was observed with some 
sera. The titer of these sera was always low (1:20) and staining 
was always limited to the lower epithelial layers. The dull 
fluorescence pattern may represent pemphigus-like antibodies 
as suggested by Chorzelski and Beutner [3]. Pemphigus-like 
antibodies have also been described in patients with extensive 
burns [11], penicillin allergy [12], trichopyton rubrum infection 
[13], cicatrical pemphigoid [14], and bullous pemphigoid [15]. 
Some of these antibodies may be removed by absorption of the 
sera with the appropriate antigen. Since the sera which pro-
duced dull fluorescence had been absorbed with red blood cell 
antigen and all sera were obtained from patients known to have 
active pemphigus, they were considered specific for pemphigus 
and were included in the statistical analysis. Epithelial nuclear 
staining was observed in 5 sera from 2 patients at a time when 
clinical remission of their disease had occurred. These anti-
bodies are not considered specific for pemphigus and may be 
removed by appropriate absorption [3]. 
In conclusion, indirect IF testing of sera from patients with 
either pemphigus vulgaris or foliaceus produces positive inter-
cellular staining on a variety of epithelial substrates. Use of 
these intercellular antibody titers to monitor disease activity 
may not be justifiable in an individual patient because of wide 
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variations in titer, however, there is a positive statistical corre-
lation between disease severity and titer when groups of pa-
tients are considered. Isolation and purification ofthe epithelial 
antigen in pemphigus may prove useful in developing a more 
reliable serological test for the diagnosis and monitoring of 
patients with pemphigus. 
The authors wish to acknowledge the expert technical assistance of 
Ms. Anita B. Ramsay. Walter F. Lever, M.D. kindly provided the serum 
samples used in this study. Statistical evaluation was performed by 
Herbert L. Cayne, Ph.D., Division of Biostatistics, Boston University 
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Announcement 
Harvard Medical School, Department of Continuing Education, in conjunction with the Beth Israel 
Hospital will sponsor a one-day seminar devoted to the use of the Argon and CO2 lasers in the treatment 
of cutaneous and vascular lesions. The course will be held on September 29, 1979, in Boston, MA under 
the direction of doctors Joel M. Noe, Seymour Rosen, Kenneth Arndt, Departments of Plastic and 
Reconstructive Surgery, Pathology, and Dermatology. For additional information please contact Dr. 
Kenneth A. Arndt, 330 Brookline Avenue, Boston, MA, 02215, (617) 735-4591. 
